BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Tempest to Present at Two Upcoming Investor Conferences in November

  Tempest Therapeutics, Inc. today announced that management will present at the following investor conferences in November: Jefferies London Healthcare Conference – Company presentation available on-demand Thursday, November 18, 2021 at 8:00 a.m. GMT

  November 9, 2021

   · 

  1 min read
• Business

  Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and Clinical Program Update

  Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and Clinical Program Update

  November 9, 2021

   · 

  14 min read
• Genetown

  Frequency Therapeutics Holds Virtual R&D Event Highlighting Clinical Advancement of FX-322, a New Potential Restorative Treatment for Hearing Loss and In Vivo Data for Its Remyelination Program in Multiple Sclerosis

  Frequency Therapeutics Holds Virtual R&D Event Highlighting Clinical Advancement of FX-322

  November 9, 2021

   · 

  9 min read
• Bio NC

  9 Meters Biopharma, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference

  9 Meters Biopharma, Inc. today announced that the Company’s CEO, John Temperato is scheduled to present at the 12th Annual Jefferies London Healthcare Conference

  November 9, 2021

   · 

  3 min read
• Business

  Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update

  Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update

  November 9, 2021

   · 

  14 min read
• Business

  PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China

  PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China

  November 9, 2021

   · 

  14 min read
• InDex Pharmaceuticals gets new patent for cobitolimod granted in the US

  InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the United States Patent and Trademark Office (USPTO).

  November 9, 2021

   · 

  3 min read
• BioCapital

  Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative

  Ceres Nanosciences is announcing the establishment of nine wastewater-based epidemiology centers of excellence, as part of the April 2021 $8.2 million award from the National Institutes of Health (NIH)

  November 9, 2021

   · 

  2 min read
• Ultimovacs’ SITC2021 Data Shows Enduring T cell Response for UV1 Combination in Melanoma

  Ultimovacs ASA will present the data will be presented as a poster at the Society For Immunotherapy of Cancer’s 36th Annual Meeting (SITC2021) being held in Washington, DC, USA November 10-14, 2021.

  November 9, 2021

   · 

  3 min read
• Lone Star Bio

  Immatics Reports Clinical Responses across Multiple Solid Tumor Types in Ongoing ACTengine® IMA203 Phase 1a Trial Targeting PRAME

  Company to host conference call on Tuesday, November 9 at 8:30 am EST Dose escalation for cell therapy candidate ACTengine® IMA203 ongoing; dose level 3 completed at doses below 1 billion transduced cells

  November 9, 2021

   · 

  14 min read